#xenograft — Friday, July 31, 2026 (1 items)
| 0 | 💬 0 |
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.
(linkinghub.elsevier.com)
|
Drug Resistance Updates 2026-07-31 | #immunotherapy #lymphoma #amr #metabolism #xenograft |